Ftse Mib
35.390,52
-0,06%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.922,58
2,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adamis Pharmaceuticals Corporation (ADMP) Adamis Pharmaceuticals Corporation (ADMP) Notizie

ADMP

Adamis Pharmaceuticals (ADMP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADMP
DataOraFonteTitoloSimboloCompagnia
08/09/202322:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/09/202318:00GlobeNewswire Inc.Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusNASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/08/202315:15GlobeNewswire Inc.Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/08/202322:38Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/08/202322:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/08/202319:43GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of $8.0 Million Public OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
03/08/202322:55Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/08/202314:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/07/202322:58Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/07/202314:30GlobeNewswire Inc.Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid ExpertNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/07/202312:08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/07/202322:37Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/06/202313:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use DisorderNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/06/202313:30GlobeNewswire Inc.Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose PreventionNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/06/202312:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/06/202321:22Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/05/202300:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/05/202322:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/05/202322:26GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/05/202318:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Reverse Stock SplitNASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/05/202322:47GlobeNewswire Inc.Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/05/202322:05GlobeNewswire Inc.Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/05/202323:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/05/202322:32Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/04/202322:53Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/202321:24GlobeNewswire Inc.Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/202320:59Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/03/202321:01GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/03/202313:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces $3.0 Million Registered Direct OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADMP

La tua Cronologia

TSX
HDI
Hardwoods Distribution
NASDAQ
UFO
Procure Space ETF
LSE
47CY
Barclays 26
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network